Newsroom
Filters: Biosimilar medicines
x
in-the-newsx
Interviu cu Adrian van den Hoven, director general Medicines for Europe […]
Read moreThe Center for Biosimilars® (CfB) spoke with Adrian van den Hoven, […]
Read moreIn the wake of the publication of Medicines for Europe’s Lessons […]
Read moreDrug shortages can greatly impact patients and the pharmaceutical industry. […]
Read moreSince the first treatment was approved in 2006, Europe has […]
Read moreOver the last ten years, generic medicines have increased access […]
Read moreAn SPC manufacturing waiver should be extremely beneficial for Europe […]
Read more